2020 National Adult and Influenza Immunization Summit Virtual Meeting

Impact of COVID-19 on Adult Immunization Coverage Rates and Update from CDC on Influenza Communications for 2020-21

July 30, 2020 | 9:00-11:00 am, CST

Although the data showing the dramatic impact of COVID-19 in reducing routine pediatric immunization coverage rates are clear, less information has been available on adult immunization. At this virtual meeting, a panel of 6 vaccine manufacturers presented their data on the impact of COVID-19 on adult immunization coverage rates in the United States and internationally. The presenters also included information on potential directions they plan to take in the fall to address the steep declines in adult immunization coverage rates that have been observed. In addition to this panel, Becton-Dickinson provided information on their ongoing work to ensure a stable supply chain of syringes and needles this fall, and CDC presented on their communications plans for the upcoming influenza season.

Please check below to view a recording of the entire panel discussion or to access individual presentations shared during the meeting.

Impact of COVID-19 on Adult Immunization Coverage Rates and Update from CDC on Influenza Communications for 2020-21

(to be posted soon)

  • Opening Welcome
    Ram Koppaka, MD, PhD
    Associate Director for Adult Immunization, Immunization Services Division
    Centers for Disease Control and Prevention (CDC)
    David Kim
    Director, Division of Vaccines
    Office of the Assistant Secretary for Health (OASH)
    L.J Tan
    Chief Strategy Officer
    Immunization Action Coalition (IAC)
  • Impact of COVID-19 Pandemic on Adult Vaccination
    (slides not posted at presenter’s request)
    Myriam Exume
    Executive Director, US Marketing Adult Vaccines
    Merck